Psychosis following treatment with topiramate;Psychose door behandeling met topiramaat

Nederlands Tijdschrift voor Geneeskunde

Volumn 146, Issue 44, 2002, Pages 2093-2095

  Verhoeven, W M A ^a   Boermans, J A J ^a   Van Der Heijden, F M M A ^a   Tuinier, S ^a  

^a VINCENT VAN GOGH INSTITUTE FOR PSYCHIATRY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; TOPIRAMATE;

ADULT; AGGRESSION; AGITATION; ARTICLE; BIPOLAR DISORDER; BODY WEIGHT DISORDER; CASE REPORT; COGNITIVE DEFECT; DRUG WITHDRAWAL; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; PSYCHOSIS; SPEECH DISORDER; SYMPTOMATOLOGY; WEIGHT REDUCTION;

ADULT; ANTICONVULSANTS; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; MALE; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 0037010227     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wong ICK, Lhatoo SD. Adverse reactions to new anticonvulsant drugs. Drug Saf 2000:23:35-56.
2. Bowden CL, Lecrubier Y, Bauer M, Goodwin G, Greil W, Sachs G, et al. Maintenance therapies for classic and other forms of bipolar disorder. J Affect Disord 2000;59 Suppl 1:S57-67.
3. Davis LL, Ryan W, Adinoff B, Petty F. Comprehensive review of the psychiatric uses of valproate. J Clin Psychopharmacol 2000;20 (1 Suppl 1):1S-17S.
4. Verhoeven WMA. Tuinier S. Cyclothymia or unstable mood disorder? A systematic treatment evaluation with valproic acid. J Appl Res Intellect Disabil 2001;14:147-54.
5. Yatham LN, Kusumakar V, Calabrese JR, Rao R, Scarrow G, Kroeker G. Third generation anticonvulsants in bipolar disorder: A review of efficacy and summary of clinical recommendations. J Clin Psychiatry 2002;6:275-83.
6. Ghaemi SN, Gaughan S. Novel anticonvulsants: A new generation of mood stabilizers? Harv Rev Psychiatry 2000;8:1-7.
7. Maidment ID. The use of topiramate in mood stabilization. Ann Pharmacother 2002:36:1277-81.
8. Post RM, Frye MA. Denicoff KD, Leverich GS, Dunn RT, Osuch EA, et al. Emerging trends in the treatment of rapid cycling bipolar disorder: A selected review. Bipolar Disord 2000:2:305-15.
9. Martin R, Kuzniecky R, Ho S, Hetherington H, Pan J. Sinclair K, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999:52:321-7.
10. Thompson PJ, Baxendale SA, Duncan JS, Sander JWAS. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000;69:636-41.
11. Besag FMC. Behavioural effects of the new anticonvulsants. Drug Saf 2001:24:513-36.
12. Swann AC. Major system toxicities and side effects of anticonvulsants. J Clin Psychiatry 2001;62 Suppl 14:S16-21.
13. Datta PK, Crawford PM. Refractory epilepsy: Treatment with new antiepileptic drugs. Seizure 2000;9:51-7.
14. Trimble MR, Rüsch N, Betts T, Crawford PM. Psychiatric symptoms after therapy with new antiepileptic drugs: Psychopathological and seizure related variables. Seizure 2000;9:249-54.
15. Kahn A, Faught E, Gilliam F, Kuzniecky R. Acute psychotic symptoms induced by topiramate. Seizure 1999:8:235-7.
16. Matthews SC, Miller BP. Auditory hallucinations associated with topiramate. J Clin Psychiatry 2001;62:653.
17. Andrade C. Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder. Bipolar Disord 2001;3:211-2.
18. Verhoeven WMA, Noten JBGM, Tuinier S, Schendel FME van. Het serotoninesyndroom; een miskende complicatie van antidepressiva. Ned Tijdschr Geneeskd 1995;139:2073-5.
19. Mellick EJM, Vries OJ de. Geneesmiddelen en ouderen: Het delirium. Geneesmiddelenbulletin 2002;36:1-9.
20. Block F, Kosinski CM. Glutamatantagonisten in der Neurologie. Nervenarzt 2001;72:393-405.